Archaeology News Online Magazine(@Archaeology_Mag) 's Twitter Profile Photo

Mummy of the Mysterious Lady may have died of cancer

A team of researchers with the Warsaw Mummy Project, has announced on their webpage that a in their collection that has come to be known as the Mysterious Lady may have had .

Mummy of the Mysterious Lady may have died of cancer

A team of researchers with the Warsaw Mummy Project, has announced on their webpage that a #mummy in their collection that has come to be known as the Mysterious Lady may have had #nasopharyngealcancer.
account_circle
Gustavo(@gusviani) 's Twitter Profile Photo

study and outcomes!!!
RCT testing WNI vs omission of lower neck in N0/1
No difference in recurrence/OS, but reduced tox
Congrats to all authors!!!👏
We need more studies like this!!

thelancet.com/journals/lanon…

#Great study and outcomes!!!
#Noninferiority RCT testing WNI vs omission of lower neck in N0/1 #nasopharyngealcancer
No difference in recurrence/OS, but reduced tox 
Congrats to all authors!!!👏
We need more studies like this!!
#headneckcancer #radonc
thelancet.com/journals/lanon…
account_circle
Ippokratis Korantzis, Medical Oncologist, MD, PhD(@newsincancer) 's Twitter Profile Photo

FDA has approved toripalimab-tpzi (Loqtorz, Coherus BioSciences) in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma (Jupiter-02 trial).
,

FDA has approved toripalimab-tpzi (Loqtorz, Coherus BioSciences) in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma (Jupiter-02 trial).
#fda, #nasopharyngealcancer
account_circle
Rory McEvoy(@rorymcevoy) 's Twitter Profile Photo

This Tuesday last year, around now, I received the horrifying news I had a rare Stage III

4 months of treatment started swiftly but was very tough. Slowly returning to normal

7 month all clear last week 🙏
Thanks for the support ❤️
Live. Every. Minute.

This Tuesday last year, around now, I received the horrifying news I had a rare Stage III #NasopharyngealCancer 

4 months of treatment started swiftly but was very tough. Slowly returning to normal

7 month all clear last week 🙏
Thanks for the support ❤️
Live. Every. Minute.
account_circle
Yusri MYM🇲🇾🇵🇸(@dryusrimusa) 's Twitter Profile Photo

Quite an emotional day + happiness in my clinic. The gentleman besides me completed his 5 yrs follow up following treatment for . He gave me a big hug n some drops of tears 😭. The other 2 guys also cancer survivors for the past 2 years.

Quite an emotional day + happiness in my clinic. The gentleman besides me completed his 5 yrs follow up following treatment for #Nasopharyngealcancer. He gave me a big hug n some drops of tears 😭. The other 2 guys also cancer survivors for the past 2 years.
account_circle
Pierre Blanchard, MD(@PBlanchardMD) 's Twitter Profile Photo

Dr Liu - Hunan Cancer Hospital

Diffusion Weighted-guided radiotherapy (+ dose escalation) superior to standard CT-guided in randomized trial of

Limitations:
1. single center
2. short FU (24 mo)
3. harmonization?

Interesting but replication needed

Dr Liu - Hunan Cancer Hospital #ASTRO20

Diffusion Weighted-guided radiotherapy (+ dose escalation) superior to standard CT-guided in randomized trial of #nasopharyngealcancer

Limitations:
1. single center
2. short FU (24 mo)
3. harmonization?

Interesting but replication needed
account_circle
Gustavo(@gusviani) 's Twitter Profile Photo

🎙️Individual 👥 meta analysis for os out !@TheLancetOncol
📊28 trials ➡️8214 👥
👉Median FU 7∙6y
👉3 treatments w/ ⬆️OS
👉 Induc w/taxanes ➡️CRT (p score 92%)
👉Induc w/o taxanes ➡️CRT (p score 87%)
CRT➡️adj CHT (p score72%)
🔚Induc &adj CHT 🔄CRT⬆️OS

🎙️Individual 👥 meta analysis for #nasopharyngealcancer os out !@TheLancetOncol 
📊28 trials ➡️8214 👥 
👉Median FU 7∙6y 
👉3  treatments w/ ⬆️OS
👉 Induc w/taxanes ➡️CRT (p score 92%)
👉Induc w/o taxanes ➡️CRT (p score 87%)
CRT➡️adj CHT  (p score72%)
🔚Induc &adj CHT 🔄CRT⬆️OS
account_circle
Melvin LK CHUA(@DrMLChua) 's Twitter Profile Photo

Speaking world tour of 3 countries, 5 cities in 11 days!!! In between running clinics and planning treatments! 😂😂

Didn’t imagine I wuld survive such a feat but Impt to showcase the work we do in at NCCS

Very thankful of my Team &Family!

Speaking world tour of 3 countries, 5 cities in 11 days!!! In between running clinics and planning treatments! 😂😂

Didn’t imagine I wuld survive such a feat but Impt to showcase the work we do in #Nosecancer #NasopharyngealCancer at NCCS  

Very thankful of my Team &Family!
account_circle
Gustavo(@gusviani) 's Twitter Profile Photo

🎙️ HFRT and conventional fractionation have similar OS in 👥w/ initial distant metastases
OncoAlert Radiotherapy & Oncology
📌Ph2 study: 35 👥 w/mNPC ➡️random HFRT (60/25fx)✖️CFRT(69.96/33fx)
🥇🎯: PFS
📊RESULTs
👉2-yPFS similar in HFRT (33.3%) and CFRT (30.0%)…

🎙️ HFRT and conventional fractionation have similar OS in 👥w/ initial distant metastases #nasopharyngealcancer
@OncoAlert @RadiotherapyOn1 
📌Ph2 study: 35 👥 w/mNPC ➡️random HFRT (60/25fx)✖️CFRT(69.96/33fx)
🥇🎯: PFS 
📊RESULTs 
👉2-yPFS similar in HFRT (33.3%) and CFRT (30.0%)…
account_circle